Studies indicate that BST2 expression is elevated in an array of neoplastic diseases, encompassing multiple myeloma, endometrial, and gastric malignancies, in addition to glioblastoma and primary pulmonary neoplasms [20–22]. Here, BST2 is linked to AL amyloidosis.